<?xml version="1.0" encoding="UTF-8"?>
<p>Although the natural reservoir identifies the dromedaries as the intermediate host, the exact modalities of species jumping with transmission to humans have not been defined [
 <xref rid="B20-microorganisms-08-01228" ref-type="bibr">20</xref>,
 <xref rid="B30-microorganisms-08-01228" ref-type="bibr">30</xref>]. Patients with MERS have, in addition to serious respiratory disorders, important intestinal complications and sometimes acute renal damage [
 <xref rid="B29-microorganisms-08-01228" ref-type="bibr">29</xref>]. This different clinical spectrum has been related to a different viral input receptor, the CD26 molecule, expressed not only by the epithelium of the lower respiratory tract but also by the intestinal and renal tract [
 <xref rid="B29-microorganisms-08-01228" ref-type="bibr">29</xref>]. As for SARS, neither effective specific drugs nor vaccines have been developed for MERS, and measures to contain and prevent secondary transmission are limited.
</p>
